These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16086787)

  • 1. Control of immune responses induced by the transfer of allogeneic white blood cells during transfusion.
    Fast LD
    Transfusion; 2005 Aug; 45(2 Suppl):44S-50S. PubMed ID: 16086787
    [No Abstract]   [Full Text] [Related]  

  • 2. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
    Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R
    Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?].
    Saas P; Bonnefoy F; Kleinclauss F; Sun Y; Tiberghien P; Gaugler B; Perruche S
    Transfus Clin Biol; 2008 Jun; 15(3):98-108. PubMed ID: 18524660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological effects of erythrocyte and leukocyte transfusion. Work Group Blood Group Serology of the Medical Advisory Commission of the College for Blood Transfusion of the Netherlands Red Cross].
    Brand A; van Rhenen DJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(3):136-40. PubMed ID: 9053759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
    Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes.
    Lee JH; Klein HG
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):585-600. PubMed ID: 11102278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
    Hashimoto D; Asakura S; Matsuoka K; Sakoda Y; Koyama M; Aoyama K; Tanimoto M; Teshima T
    Eur J Immunol; 2007 Jan; 37(1):271-81. PubMed ID: 17154260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct pathway of human T-Cell allorecognition is not tolerized by stimulation with allogeneic peripheral blood mononuclear cells irradiated with high-dose ultraviolet B.
    Wallgren AC; Alder J; Andersson B; Karlsson-Parra A; Bäcker AE
    Scand J Immunol; 2006 Feb; 63(2):90-6. PubMed ID: 16476007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion.
    Porter D; Levine JE
    Semin Hematol; 2006 Jan; 43(1):53-61. PubMed ID: 16412789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-associated graft-versus-host disease (TA-GVHD): cellular mechanisms and their possible modulation by ultraviolet radiation.
    Andreu G; Fressy P
    Transfus Sci; 1995 Jun; 16(2):109-13. PubMed ID: 10155724
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic transplantation for myelodysplastic syndrome (MDS).
    Ingram W; Lim ZY; Mufti GJ
    Blood Rev; 2007 Mar; 21(2):61-71. PubMed ID: 16759774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
    Stelljes M; Specht C; Albring J; Volkmann S; Schlösser V; Pauels HG; Poremba C; Bisping G; Opitz C; Scheffold C; Silling G; Kiehl M; Berdel WE; Kienast J
    Transplantation; 2007 Feb; 83(3):314-22. PubMed ID: 17297406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of blood irradiation: determination T cells radiosensitivity to cobalt-60 gamma rays.
    Góes EG; Borges JC; Covas DT; Orellana MD; Palma PV; Morais FR; Pelá CA
    Transfusion; 2006 Jan; 46(1):34-40. PubMed ID: 16398728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
    Spierings E
    Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host reaction after leukocyte transfusion.
    Hong R
    J Pediatr; 1994 Oct; 125(4):672. PubMed ID: 7931897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.